Philip George Kuttikat

Medical oncology consultant/specialist with over 10 years experience in managing oncology patients. I have worked in tertiary care oncology hospitals (both public and private sector). Skilled in chemotherapy, immunotherapy, targeted therapy and hormonal treatment of cancer. Currently based in Kerala (India), available to join on short notice. Being a dynamic individual, I bring a strong academic foundation in medical oncology and hands-on experience gained through professional career.

I have DHA active registration in Medical oncology - DHA ID: 43777299

• AMPOK, Association of Medical and Paediatric Oncologists of Kerala
• ESMO, European Society of Medical Oncology
• Indian Medical Association, Life member
• Association of Radiation Oncologists of India, Member (LM Number - 1395)

• Apollo cancer conclave and Cancer CI, 02/01/20, Hyderabad
• Symposium on acute lymphoblastic lymphoma, 02/01/20, Ahmedabad
• QURE Haematology conference 2020, 01/18/20 - 01/19/20, Ahmedabad
• 2nd Uro oncology update, 11/24/19, Ahmedabad
• JIC Oncology symposium, 01/04/19 - 01/06/19, Ahmedabad
• ESTRO - AROI Advanced Technologies Course, 10/01/14, Chennai
• 12th TMH annual radiotherapy practicum, 10/01/14, Mumbai
• CME on Recent Trends in Management of Breast and Gynaecologic Cancers, 03/01/13, Chandigarh
• 18th North Zone AROICON, 09/01/12, Bathinda
• 17th North Zone Association of Radiation Oncologists of India Conference NZAROION, 10/01/11, Chandigarh
• 8th ICRO/AROI - Indian College of Radiation Oncology - Teaching course on 'Paediatric Oncology and Haematological Malignancies', 05/01/10, CMC Vellore
• AROICON 2010. 32nd National Conference of Association of Radiation Oncologists of India, 11/01/10, Patna
• 15th Annual conference of Northern Chapter of AROI, 10/01/09, New Delhi
• CME on Recent Advances in Management of Head and Neck Cancer, 05/01/09, Chandigarh
• Course on research methodology and biostatistics, 10/01/08, Chandigarh

Dr. Mereena George, MS Obstetrics and Gynecology, Consultant OBG, Samaritan hospital, Kerala, India

• Successful rechallenge of bevacizumab after grade 4 bevacizumab induced hypertension in a case of carcinoma ovary, is rechallenging an option? - a rare case report., Satish Sharma, Apurva A Patel, Philip G. Kuttikat et al., GSC Biological and pharmaceutical sciences, 2022, 18, 03, 030-034
• Topotecan plus cyclophosphamide as a salvage regimen in patients with relapsed/refractory paediatric type tumors., Philip George Kuttikat, Apurva A. Patel, Ananya Pareek, Shantanu Pendse, A. Harshavardhan, Harsha P. Panchal., International Journal of Current Research, 2021, 13, 04, 16901-16905
• Impact of nationwide lockdown on cancer care during COVID-19 pandemic: A retrospective analysis from western India., Ananya Pareek, Apurva A Patel, A.Harshavardhan, Philip G. Kuttikat et al., Diabetes Metab Syndr., 2021, 15, 4
• Nivolumab in recurrent/metastatic squamous cell carcinoma of head and neck: A tertiary cancer centre experience., Ananya Pareek, Apurva Patel, Mukesh Kumar, Philip G. Kuttikat et al., South Asian J Cancer, 2021, 00, 1-4
• Late-term effects of hypofractionated chest wall and regional nodal radiotherapy with two-dimensional technique in patients with breast cancer., Yadav BS, Bansal A, Kuttikat PG, Das D, Gupta A, Dahiya D., Radiat Oncol J., 2020, 38, 2, 109-118
• A case report of peritoneal malignant mesothelioma presenting as primary ovarian mass., Kapoor R, Kuttikat PG, Vaiphei K, Rai B, Patel FD., J Can Res Ther, 2015, 11, 654
• Osteosarcoma of larynx: A rare case report with review of literature., Bahl A, George P, Bhattacharyya T, Ghoshal S, Bakshi J, Das A., J Can Res Ther, 2015, 11, 1038
• Primary non-Hodgkin lymphoma of the ovary., Yadav BS, George P, Sharma SC, Gorsi U, McClennan E, Martino MA, Chapman J, Chen LM, Prakash G, Malhotra P, Tantravahi SK, Glenn MJ, Werner TL, Baksh K, Sokol L, Morris GJ., Semin Oncol., 2014, 41, 3, e19-30
• Post-mastectomy radiation beyond chest wall in patients with N1 breast cancer: is there a benefit?, Yadav BS, Sharma SC, George P, Bansal A., J Cancer Res Ther., 2014, 10, 2, 279-83
• Quad Shot: an effective course of palliative radiation. Comparing two-day schedule with conventional two weeks radiation., Sushmita Ghoshal, Philip Kuttikat, Satyawati Mohindra., LAP LAMBERT Academic Publishing, 07/04/12

• Winner Quiz competition - Lung cancer masterclass under the aegis of cancer research and statistics foundation, 07/01/20
• E-poster - Topotecan plus cyclophosphamide as a salvage regimen in patients with relapsed/refractory paediatric type tumors, ISMPOCON, 11/01/20
• Poster presentation - Clinico-pathological profile and treatment outcomes in patients of prostate cancer from a regional cancer center of western India, Joint international conference, 01/01/19, Ahmedabad
• Factors affecting overall survival and disease-free survival in breast cancer, 18th Annual NZAROICON, 09/01/12, Bathinda
• A comparative evaluation of quad shot regimen with the standard regimen of palliative radiotherapy in advanced head and neck cancers, 15th Annual conference of Northern Chapter of AROI, 10/01/09, New Delhi

I solemnly affirm that the above mentioned statements are true., 15/7/25, Dr. Philip George Kuttikat